Genbot Injection contains Gentamicin 40 mg along with Methylparaben (0.18% w/v) and Propyl Paraben (0.02% w/v) as preservatives. Gentamicin is a broad-spectrum aminoglycoside antibiotic used to treat serious infections caused by bacteria, especially Gram-negative organisms. It works by inhibiting bacterial protein synthesis, thereby stopping the growth and multiplication of harmful microbes.
It helps in the antibiotic and critical-care segment, playing an important role in managing severe infections like septicemia, respiratory tract infections, urinary tract infections, intra-abdominal infections, and post-operative wound infections. The addition of Methylparaben and Propyl Paraben ensures the formulation’s microbial stability and prolonged shelf life.
Clinically, Gentamicin Injection is often used in hospitals and critical-care setups for patients requiring rapid and effective antibiotic coverage. It is administered intramuscularly or intravenously under medical supervision, providing strong bactericidal activity against difficult-to-treat infections.
From a B2B and PCD franchise perspective, Genbot Injection represents a high-demand hospital-care antibiotic with consistent requirements across India. Its formulation quality, WHO-GMP-certified manufacturing, and wide therapeutic application make it an excellent addition to any general, critical-care, or injectable medicine division.